Rang	Name	Position
1	Dr. Seth Lederman M.D.	Co-Founder, Interim Chief Medical Officer, President, CEO & Chairman
2	Mr. Bradley Saenger CPA	CFO & Treasurer
3	Mrs. Jessica Edgar Morris	Chief Operating Officer
4	Dr. Gregory M. Sullivan M.D.	Secretary
5	Ms. Siobhan Fogarty B.Sc., M.Sc.	Chief Technical Officer
6	Ms. Irina Ishak	General Counsel
7	Dr. Darryl Rideout Ph.D.	Executive Vice President of Experimental Chemistry
8	Dr. Sina Bavari Ph.D.	Executive Vice President of Infectious Disease Research & Development
9	Dr. Zeil Rosenberg M.D., M.P.H.	Executive Vice President of Medical
10	Mr. Thomas Englese M.B.A.	Chief Commercial Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,15%	10,76 Mio. USD
2	Point72 Asset Management, L.P.	6,80%	8,98 Mio. USD
3	Millennium Management LLC	5,64%	7,44 Mio. USD
4	AQR Capital Management LLC	5,15%	6,79 Mio. USD
5	Vanguard Capital Management, LLC	4,03%	5,32 Mio. USD
6	Jones Hill Capital LP	3,65%	4,81 Mio. USD
7	Geode Capital Management, LLC	2,30%	3,04 Mio. USD
8	Ishara Investments LP	1,97%	2,60 Mio. USD
9	State Street Corp	1,58%	2,09 Mio. USD
10	UBS Group AG	1,35%	1,78 Mio. USD
11	Citadel Advisors Llc	1,14%	1,51 Mio. USD
12	Essex Investment Management Company, LLC	0,96%	1,27 Mio. USD
13	Balyasny Asset Management LLC	0,77%	1,02 Mio. USD
14	Northern Trust Corp	0,70%	0,93 Mio. USD
15	Nuveen, LLC	0,68%	0,90 Mio. USD
16	Vanguard Fiduciary Trust Co	0,60%	0,79 Mio. USD
17	Vanguard Portfolio Management, LLC	0,57%	0,75 Mio. USD
18	FMR Inc	0,55%	0,72 Mio. USD
19	IEQ CAPITAL, LLC	0,54%	0,71 Mio. USD
20	Susquehanna Portfolio Strategies LLC	0,38%	0,50 Mio. USD